EHCEncompass Health Corporation

$120.75

Price

$120.75+4.2%1Y
1M+8.7%1Y+4.2%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Above average
8/10
Value64
Quality84
Momentum35
Growth54
Strongest Quality, weakest Momentum · ranked vs Healthcare peers. The five questions below judge the company on its own terms.
What they do

We are the nation’s largest owner and operator of inpatient rehabilitation hospitals in terms of patients treated, revenues, and number of hospitals. We provide specialized rehabilitative treatment, using advanced technology and intensive therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence and quality of life. We operate hospitals in 39 states and Puerto Rico, with concentrations in Florida and Texas.

In the company’s own words · 10-K filed Feb 26, 2026 · SEC EDGAR

P/E (TTM)19.7
Market Cap$9.72B
1Y Return+4.2%
5Y Return+89%

Business segments

Q1 2026 · $1.64B

The company’s own SEC segment disclosure.

  • Medicare$1.04B63%
  • Medicare Advantage$257.6M16%
  • Managed Care$167.7M10%
  • Other$52.9M3%
  • Other Income Source$50.8M3%
  • Medicaid$46.1M3%
  • Other (3)$25.9M2%

Encompass Health Corporation (EHC) reported revenue of $1.60B in Q2 2026 (quarter ended June 30, 2026), up 9.6% from the same quarter a year earlier. That came with net income of $154M (9.6% of revenue). For the full year FY2025, revenue was $5.94B (+10% year on year) and net income $566M. Its largest product in 2026-Q1 was Medicare at $1.04B, 63% of the disclosed total, just ahead of Medicare Advantage at 16%.

Raw charts

10 series · TTM

As reported to the SEC, without any scoring.